相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Post-translational modifications of EZH2 in cancer
Zhongwei Li et al.
CELL AND BIOSCIENCE (2020)
EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells
Shuo Huang et al.
CANCER RESEARCH (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
MicroRNA-145 Inhibits Cell Migration and Invasion in Colorectal Cancer by Targeting TWIST
Xuning Shen et al.
ONCOTARGETS AND THERAPY (2019)
Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
Andrei M. Mikheev et al.
MOLECULAR ONCOLOGY (2018)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples
Jinquan Cai et al.
ONCOIMMUNOLOGY (2018)
EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
Yatao Yin et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Upholding a role for EMT in breast cancer metastasis
Xin Ye et al.
NATURE (2017)
The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells
Tianfu Yu et al.
ONCOTARGET (2017)
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
Kei Ihira et al.
ONCOTARGET (2017)
miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers
Haiyu Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Role of EMT in Metastasis and Therapy Resistance
Bethany N. Smith et al.
JOURNAL OF CLINICAL MEDICINE (2016)
siRNA Silencing EZH2 Reverses Cisplatin-resistance of Human Non-small Cell Lung and Gastric Cancer Cells
Wen Zhou et al.
Asian Pacific Journal of Cancer Prevention (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
Paula de Robles et al.
NEURO-ONCOLOGY (2015)
Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells
Dimitrios Cakouros et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Cost of migration: Invasion of malignant gliomas and implications for treatment
A Giese et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
分享论文
